Smith G K, Mueller W T, Slieker L J, DeBrosse C W, Benkovic S J
Biochemistry. 1982 Jun 8;21(12):2870-4. doi: 10.1021/bi00541a010.
It is shown that the transfer of formyl units in the de novo purine biosynthetic pathway as catalyzed by glycinamide ribonucleotide (GAR) transformylase and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase probably proceeds through a direct displacement mechanism involving only formyl donor (10-CHO-H4folate) and formyl acceptor (GAR or AICAR). The inability to observe enzyme-catalyzed solvent oxygen incorporation or uncoupling by hydroxylamine of 1:1 stoichiometry between formylated acceptor [formylglycinamide ribonucleotide or 5-(formylamino)imidazole-4-carboxamide ribonucleotide] and deformylated donor implies the absence of an amidine intermediate and suggests that either a formylated enzyme-bound intermediate is not formed or such an intermediate is not accessible to hydroxylamine.
结果表明,在从头嘌呤生物合成途径中,由甘氨酰胺核糖核苷酸(GAR)转甲酰酶和5-氨基咪唑-4-甲酰胺核糖核苷酸(AICAR)转甲酰酶催化的甲酰基单元转移可能通过仅涉及甲酰基供体(10-CHO-H4叶酸)和甲酰基受体(GAR或AICAR)的直接取代机制进行。无法观察到酶催化的溶剂氧掺入或羟胺对甲酰化受体[甲酰甘氨酰胺核糖核苷酸或5-(甲酰氨基)咪唑-4-甲酰胺核糖核苷酸]与去甲酰化供体之间1:1化学计量的解偶联,这意味着不存在脒中间体,并表明要么未形成甲酰化的酶结合中间体,要么羟胺无法接近这样的中间体。